NYSEARCA:MNK - NYSE Arca - IE000O3L0NQ3 - Common Stock - Currency: USD
0.3402
-0.06 (-14.97%)
The current stock price of MNK is 0.3402 USD. In the past month the price decreased by -68.5%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
LLY | ELI LILLY & CO | 67.21 | 829.40B | ||
NVO | NOVO-NORDISK A/S-SPONS ADR | 27.44 | 390.99B | ||
JNJ | JOHNSON & JOHNSON | 16.25 | 390.76B | ||
AZN | ASTRAZENECA PLC-SPONS ADR | 20.56 | 230.17B | ||
MRK | MERCK & CO. INC. | 11.71 | 226.40B | ||
NVS | NOVARTIS AG-SPONSORED ADR | 13.77 | 215.98B | ||
PFE | PFIZER INC | 8.46 | 149.04B | ||
SNY | SANOFI-ADR | 13.58 | 136.54B | ||
BMY | BRISTOL-MYERS SQUIBB CO | 48.97 | 113.23B | ||
GSK | GSK PLC-SPON ADR | 7.78 | 74.77B | ||
ZTS | ZOETIS INC | 27.1 | 72.39B | ||
TAK | TAKEDA PHARMACEUTIC-SP ADR | 31.95 | 44.58B |
Mallinckrodt Plc engages in the development, manufacture, market, adn distribution of both branded and generic specialty pharmaceutical products and medical imaging agents. The firm operates in two reportable segments: Specialty Brands and Specialty Generics. The Specialty Brands includes specialty pharmaceutical brands. The Specialty Generics includes niche specialty generic drugs and active pharmaceutical ingredients. Its Specialty Generics segment is focused on providing its customers with specialty generic drugs and active pharmaceutical ingredients (APIs). The firm focuses on various therapeutic areas, such as autoimmune and rare diseases in specialty areas like neurology, rheumatology, hepatology, nephrology, pulmonology, ophthalmology, and oncology; immunotherapy and neonatal respiratory critical care therapies; analgesics, cultured skin substitutes and gastrointestinal products. Its product portfolio includes Acthar Gel, INOmax, Therakos photopheresis, StrataGraft, Terlivaz, and Amitiza.
MALLINCKRODT PLC
College Business & Technology Park, Cruiserath,, Blanchardstown
DUBLIN D15 IE
CEO: Mark C. Trudeau
Employees: 2700
Company Website: https://www.mallinckrodt.com/
The current stock price of MNK is 0.3402 USD. The price decreased by -14.97% in the last trading session.
The exchange symbol of MALLINCKRODT PLC is MNK and it is listed on the NYSE Arca exchange.
MNK stock is listed on the NYSE Arca exchange.
MALLINCKRODT PLC (MNK) has a market capitalization of 4.48M USD. This makes MNK a Nano Cap stock.
MALLINCKRODT PLC (MNK) currently has 2700 employees.
MALLINCKRODT PLC (MNK) has a resistance level at 0.62. Check the full technical report for a detailed analysis of MNK support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
MNK does not pay a dividend.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | N/A | ||
ROE | N/A | ||
Debt/Equity | N/A |
ChartMill assigns a Buy % Consensus number of 42% to MNK. The Buy consensus is the average rating of analysts ratings from 8 analysts.